FDA 483 - Itamar Medical Ltd. - January 10, 2011

The provided text does not contain the substantive information typically found within an FDA 483 document necessary to generate a comprehensive summary. The input consists exclusively of administrative notes pertaining to a Freedom of Information Act (FOIA) request (2018-6760) and contact details for FDA/CDRH/OCE/DID. An FDA 483 is issued by FDA investigators to management at the conclusion of an inspection when they observe conditions or practices that may violate the Federal Food, Drug, and Cosmetic Act or other related acts. Such a document would typically identify the inspected company, specific inspection dates, detailed observations of regulatory deficiencies or main violations, reference the applicable regulatory framework (e.g., Quality System Regulation 21 CFR Part 820), and imply required corrective actions by the company to address the noted issues. Since these crucial elements are absent from the provided content, a summary detailing company name, inspection dates, main violations, regulatory framework, and required actions cannot be accurately produced.